◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Knight Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Total Revenue 371.3M 328.2M 293.6M 243.5M
Operating Revenue 371.3M 328.2M 293.6M 243.5M
Cost Of Revenue 196.9M 175.5M 155.5M 128.1M
Gross Profit 174.4M 152.7M 138.1M 115.4M
Selling General And Administration 99.3M 83.7M 88.6M 74.4M
General And Administrative Expense 45.5M 37.4M 40.1M 35.3M
Research And Development 23.3M 17.5M 14.8M 12.7M
Depreciation And Amortization In Income Statement 44.4M 45.0M 51.7M 41.2M
Operating Expense 167.0M 146.3M 155.1M 128.2M
Operating Income 7.4M 6.4M -17.1M -12.8M
EBIT 11.3M -9.5M -37.4M 10.3M
Interest Expense 9.2M 12.5M 6.6M 3.6M
Interest Expense Non Operating 9.2M 12.5M 6.6M 3.6M
Interest Income 10.4M 12.6M 10.6M 7.4M
Interest Income Non Operating 10.4M 12.6M 10.6M 7.4M
Net Interest Income 1.2M 87,000 4.0M 3.8M
Other Income Expense -6.5M -28.4M -30.9M 15.8M
Other Non Operating Income Expenses -129,000 2.9M 4.0M 128,000
Special Income Charges 9.2M -6.0M -21.7M 423,000
Gain On Sale Of Security -15.6M -25.4M -13.2M 15.2M
Pretax Income 2.1M -22.0M -44.0M 6.7M
Tax Provision -2.3M -5.2M -14.1M -9.0M
Tax Effect Of Unusual Items -960,450 -7.3M -11.2M 4.1M
Net Income From Continuing And Discontinued Operation 4.3M -16.8M -29.9M 15.7M
Net Income From Continuing Operation Net Minority Interest 4.3M -16.8M -29.9M 15.7M
Net Income Including Noncontrolling Interests 4.3M -16.8M -29.9M 15.7M
Minority Interests -- -- -- 0.00
Net Income Common Stockholders 4.3M -16.8M -29.9M 15.7M
Net Income 4.3M -16.8M -29.9M 15.7M
EBITDA 64.4M 40.9M 25.3M 58.2M
Normalized EBITDA 70.8M 72.2M 60.2M 42.6M
Reconciled Depreciation 53.1M 50.4M 62.6M 47.9M
Basic EPS 0.04 -0.16 -0.26 0.13
Diluted EPS 0.04 -0.16 -0.26 0.13
Basic Average Shares 101.0M 107.5M 114.9M 124.5M
Diluted Average Shares 101.4M 107.5M 114.9M 124.5M
Total Unusual Items -6.4M -31.4M -35.0M 15.6M
Total Unusual Items Excluding Goodwill -6.4M -31.4M -35.0M 15.6M
Tax Rate For Calcs 0.15 0.23 0.32 0.27
Normalized Income 9.8M 7.2M -6.1M 4.2M
Amortization 44.4M 45.0M 51.7M 41.2M
Amortization Of Intangibles Income Statement 44.4M 45.0M 51.7M 41.2M
Depreciation Amortization Depletion Income Statement 44.4M 45.0M 51.7M 41.2M
Diluted NI Availto Com Stockholders 4.3M -16.8M -29.9M 15.7M
Impairment Of Capital Assets 0.00 9.3M 24.0M 0.00
Net Income Continuous Operations 4.3M -16.8M -29.9M 15.7M
Net Non Operating Interest Income Expense 1.2M 87,000 4.0M 3.8M
Other Gand A 45.5M 37.4M 40.1M 35.3M
Other Special Charges -9.2M -3.3M -2.3M -423,000
Reconciled Cost Of Revenue 188.1M 170.2M 144.6M 121.3M
Selling And Marketing Expense 53.9M 46.3M 48.5M 39.1M
Total Expenses 363.9M 321.8M 310.6M 256.3M
Total Operating Income As Reported 7.4M -2.9M -41.0M -12.8M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Cash And Cash Equivalents 80.1M 58.8M 71.7M 86.0M
Cash Cash Equivalents And Short Term Investments 172.8M 170.2M 191.2M 163.0M
Cash Equivalents 5.1M 325,000 302,000 9.0M
Cash Financial 75.0M 58.4M 71.4M 76.9M
Other Short Term Investments 92.7M 111.4M 119.5M 77.0M
Accounts Receivable 105.2M 88.7M 94.9M 55.4M
Receivables 113.5M 98.2M 108.6M 67.4M
Inventory 102.7M 91.8M 92.5M 72.4M
Prepaid Assets 7.7M 4.9M 3.3M 2.2M
Current Assets 396.8M 365.1M 395.6M 307.3M
Gross PPE 68.3M 39.5M 56.1M 41.0M
Accumulated Depreciation -48.2M -21.6M -33.4M -11.1M
Net PPE 20.0M 17.9M 22.6M 29.9M
Goodwill 86.5M 79.8M 82.3M 75.4M
Goodwill And Other Intangible Assets 370.1M 369.8M 421.1M 425.7M
Other Intangible Assets 283.6M 290.0M 338.8M 350.3M
Investments And Advances 103.4M 120.0M 158.0M 179.0M
Other Non Current Assets -- -- -- 2.4M
Total Non Current Assets 567.0M 580.4M 659.2M 684.6M
Total Assets 963.8M 945.5M 1.1B 991.9M
Current Debt 17.5M 17.9M 17.7M 26.7M
Current Debt And Capital Lease Obligation 20.1M 19.6M 20.3M 28.3M
Accounts Payable 78.3M 85.4M 106.1M 65.3M
Payables 89.2M 93.4M 115.3M 75.0M
Payables And Accrued Expenses 89.2M 93.4M 115.3M 75.0M
Other Current Liabilities 1.9M 1.0M 5.8M 2.0M
Current Liabilities 111.2M 114.0M 141.3M 105.3M
Long Term Debt 25.9M 44.0M 52.4M 9.3M
Long Term Debt And Capital Lease Obligation 29.3M 49.5M 57.4M 12.7M
Long Term Capital Lease Obligation 3.4M 5.5M 5.0M 3.4M
Total Non Current Liabilities Net Minority Interest 57.4M 84.6M 87.7M 44.6M
Total Liabilities Net Minority Interest 168.7M 198.6M 229.0M 149.9M
Common Stock 534.3M 540.0M 599.1M 628.9M
Capital Stock 534.3M 540.0M 599.1M 628.9M
Additional Paid In Capital 25.7M 26.0M 23.7M 21.8M
Retained Earnings 154.8M 150.9M 161.8M 191.6M
Gains Losses Not Affecting Retained Earnings 80.2M 29.8M 41.3M -376,000
Other Equity Adjustments 80.2M 29.8M 41.3M -376,000
Common Stock Equity 795.1M 746.9M 825.9M 842.0M
Stockholders Equity 795.1M 746.9M 825.9M 842.0M
Total Equity Gross Minority Interest 795.1M 746.9M 825.9M 842.0M
Total Capitalization 821.0M 790.9M 878.3M 851.3M
Net Tangible Assets 425.0M 377.1M 404.8M 416.3M
Tangible Book Value 425.0M 377.1M 404.8M 416.3M
Working Capital 285.6M 251.1M 254.3M 202.0M
Invested Capital 838.5M 808.7M 895.9M 877.9M
Total Debt 49.5M 69.1M 77.7M 41.0M
Net Debt -- 3.1M -- --
Share Issued 100.0M 101.2M 112.2M 117.8M
Ordinary Shares Number 100.0M 101.2M 112.2M 117.8M
Accrued Interest Receivable 845,000 1.0M 4.5M 1.5M
Assets Held For Sale Current -- -- 0.00 2.4M
Available For Sale Securities 103.4M 120.0M 158.0M 179.0M
Buildings And Improvements 18.5M 9.8M 14.6M 7.7M
Capital Lease Obligations 6.1M 7.2M 7.6M 5.0M
Current Capital Lease Obligation 2.6M 1.7M 2.6M 1.6M
Finished Goods 84.9M 80.4M 79.2M 58.8M
Income Tax Payable 213,000 1.2M 2.3M 7.1M
Investment Properties -- -- 0.00 1.5M
Investmentin Financial Assets 103.4M 120.0M 158.0M 179.0M
Land And Improvements 8,000 926,000 1.6M 1.1M
Machinery Furniture Equipment 42.6M 21.9M 33.1M 25.9M
Non Current Accounts Receivable 3.4M 4.0M 3.4M 1.8M
Non Current Deferred Assets 21.2M 19.4M 9.3M 2.0M
Non Current Deferred Liabilities 3.8M 2.8M 4.4M 12.4M
Non Current Deferred Taxes Assets 21.2M 19.4M 9.3M 2.0M
Non Current Deferred Taxes Liabilities 3.8M 2.8M 4.4M 12.4M
Non Current Prepaid Assets 48.8M 49.3M 44.8M 44.6M
Other Current Borrowings 17.5M 17.9M 17.7M 26.7M
Other Equity Interest 117,000 117,000 117,000 117,000
Other Payable 10.7M 6.9M 6.9M 2.7M
Other Properties 7.2M 6.8M 6.8M 6.3M
Other Receivables 1.9M 3.9M 4.0M 2.3M
Properties 0.00 0.00 0.00 0.00
Raw Materials 12.1M 8.4M 10.8M 11.2M
Taxes Receivable 5.6M 4.6M 5.2M 8.2M
Total Tax Payable 213,000 1.2M 2.3M 7.1M
Tradeand Other Payables Non Current 24.3M 32.3M 25.8M 19.5M
Treasury Shares Number -- 0.00 -- --
Work In Process 5.7M 3.0M 2.5M 2.4M
Line Item FY 2024Dec 31, 2024 FY 2023Dec 31, 2023 FY 2022Dec 31, 2022 FY 2021Dec 31, 2021
Operating Cash Flow 36.3M 35.9M 45.0M 44.6M
Cash Flow From Continuing Operating Activities 36.3M 35.9M 45.0M 44.6M
Depreciation And Amortization 53.1M 50.4M 62.6M 47.9M
Depreciation Amortization Depletion 53.1M 50.4M 62.6M 47.9M
Stock Based Compensation 1.9M 2.3M 1.9M 3.0M
Deferred Tax -3.2M -9.1M -17.1M -7.6M
Deferred Income Tax -3.2M -9.1M -17.1M -7.6M
Change In Working Capital -19.6M -28.0M -5.5M 627,000
Changes In Account Receivables -8.3M 5.2M -31.1M 6.2M
Change In Receivables -10.3M 5.6M -30.0M 8.6M
Change In Inventory -5.9M 698,000 -11.4M -17.2M
Change In Payables And Accrued Expense -4,000 -22.8M 36.6M 4.6M
Change In Payable -4,000 -22.8M 36.6M 4.6M
Change In Other Current Liabilities 911,000 -5.1M -317,000 1.1M
Other Non Cash Items 165,000 10.3M -3.2M 559,000
Capital Expenditure -31.5M -10.0M -25.8M -224.2M
Purchase Of PPE -2.5M -950,000 -2.9M -3.8M
Net PPE Purchase And Sale -2.4M 974,000 -2.9M -3.8M
Purchase Of Investment -162.6M -334.2M -185.5M -64.3M
Sale Of Investment 210.8M 347.9M 150.5M 180.5M
Net Investment Purchase And Sale 48.2M 13.7M -34.9M 116.2M
Investing Cash Flow 17.0M 29.3M -63.1M -105.3M
Cash Flow From Continuing Investing Activities 17.0M 29.3M -63.1M -105.3M
Issuance Of Debt 3.5M 4.8M 51.8M 9.4M
Repayment Of Debt -21.5M -22.8M -20.3M -23.6M
Net Issuance Payments Of Debt -18.1M -18.0M 31.5M -14.2M
Repurchase Of Capital Stock -8.9M -53.5M -30.1M -64.4M
Net Common Stock Issuance -8.9M -53.5M -30.1M -64.4M
Common Stock Payments -8.9M -53.5M -30.1M -64.4M
Financing Cash Flow -33.5M -81.0M -2.8M -78.3M
Cash Flow From Continuing Financing Activities -33.5M -81.0M -2.8M -78.3M
Effect Of Exchange Rate Changes 1.6M 2.8M 6.6M -4.7M
Changes In Cash 19.7M -15.7M -20.8M -139.0M
Beginning Cash Position 58.8M 71.7M 86.0M 229.6M
End Cash Position 80.1M 58.8M 71.7M 86.0M
Free Cash Flow 4.8M 26.0M 19.2M -179.6M
Income Tax Paid Supplemental Data 5.5M 5.4M 5.7M 8.6M
Interest Paid Supplemental Data 7.6M 9.9M 4.5M 2.6M
Amortization Cash Flow 44.4M 45.0M -- --
Amortization Of Intangibles 44.4M 45.0M -- --
Asset Impairment Charge 0.00 9.3M 24.0M 496,000
Cash Dividends Paid 0.00 0.00 0.00 --
Change In Account Payable 632,000 -21.6M 35.1M 11.5M
Change In Income Tax Payable -636,000 -1.2M 1.5M -6.9M
Change In Prepaid Assets -4.3M -6.4M -394,000 3.6M
Change In Tax Payable -636,000 -1.2M 1.5M -6.9M
Depreciation 8.8M 5.4M -- 47.9M
Gain Loss On Investment Securities 11.4M 10.2M 20.7M -18.9M
Gain Loss On Sale Of PPE -- -- -- 496,000
Interest Paid Cff -7.6M -9.9M -4.5M --
Long Term Debt Issuance 3.5M 4.8M 51.8M 9.4M
Long Term Debt Payments -21.5M -22.8M -20.3M -23.6M
Net Foreign Currency Exchange Gain Loss -11.8M 7.4M -8.5M 2.9M
Net Income From Continuing Operations 4.3M -16.8M -29.9M 15.7M
Net Intangibles Purchase And Sale -29.0M -9.0M -22.9M -220.4M
Net Long Term Debt Issuance -18.1M -18.0M 31.5M -14.2M
Net Other Investing Changes 97,000 23.6M -2.3M 2.7M
Operating Gains Losses -319,000 17.6M 12.2M -16.1M
Proceeds From Stock Option Exercised 1.0M 380,000 340,000 297,000
Purchase Of Intangibles -29.0M -9.0M -22.9M -220.4M
Sale Of PPE 100,000 1.9M 0.00 --
NEWS
Loading news...
TRENDING
Loading...